SWHY(SZ:000166) 申万宏源证券上海北京西路营业部·2025-03-05 01:40Core Viewpoint - The successful issuance of the "Shanghai Fengxian Biotechnology Park Development Co., Ltd. 2025 Non-Public Corporate Bonds (First Phase)" led by Shenwan Hongyuan marks a significant milestone, achieving a record low interest rate for private bonds of the same duration and rating in Shanghai [1] Group 1: Bond Issuance Details - The bond issuance scale is 1 billion yuan, with a term of 3+2 years and a coupon rate of 1.80% [1] - The issuance received a subscription multiple of 4.56, indicating strong investor interest [1] Group 2: Issuer Background - The issuer is a first-level state-owned enterprise under the Shanghai Fengxian District, serving as the sole developer within the Shanghai Fengxian Biotechnology Park [1] - The biotechnology park is identified as a core area of the "Oriental Beauty Valley" development strategy by the Shanghai Fengxian District [1] Group 3: Strategic Goals - The park aims to align with Shanghai's strategy to become a globally influential technology innovation center and the district's goals of enhancing its beauty and strength [1] - The focus is on optimizing industrial positioning and developing the beautiful health industry, while actively pursuing external investments and strategic collaborations [1] Group 4: Future Collaboration - This bond issuance represents a continued partnership between Shenwan Hongyuan and the issuer, laying a solid foundation for future business cooperation [1] - Shenwan Hongyuan aims to serve national strategies and the real economy, promoting high-quality regional economic development [1]